Home/Filings/4/0001209191-12-002793
4//SEC Filing

Webb Michael J. 4

Accession 0001209191-12-002793

CIK 0001333170other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 4:30 PM ET

Size

5.2 KB

Accession

0001209191-12-002793

Insider Transaction Report

Form 4
Period: 2012-01-05
Webb Michael J.
SVP, Quality & Regulatory
Transactions
  • Sale

    Common Stock

    2012-01-05$18.01/sh5,874$105,8197,568 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 19,2011.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.10. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001409195

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:30 PM ET
Size
5.2 KB